Literature DB >> 22460341

The impact of lesion in-painting and registration methods on voxel-based morphometry in detecting regional cerebral gray matter atrophy in multiple sclerosis.

A Ceccarelli1, J S Jackson, S Tauhid, A Arora, J Gorky, E Dell'Oglio, A Bakshi, T Chitnis, S J Khoury, H L Weiner, C R G Guttmann, R Bakshi, M Neema.   

Abstract

BACKGROUND AND
PURPOSE: VBM has been widely used to study GM atrophy in MS. MS lesions lead to segmentation and registration errors that may affect the reliability of VBM results. Improved segmentation and registration have been demonstrated by WM LI before segmentation. DARTEL appears to improve registration versus the USM. Our aim was to compare the performance of VBM-DARTEL versus VBM-USM and the effect of LI in the regional analysis of GM atrophy in MS.
MATERIALS AND METHODS: 3T T1 MR imaging scans were acquired from 26 patients with RRMS and 28 age-matched NC. LI replaced WM lesions with normal-appearing WM intensities before image segmentation. VBM analysis was performed in SPM8 by using DARTEL and USM with and without LI, allowing the comparison of 4 VBM methods (DARTEL + LI, DARTEL - LI, USM + LI, and USM - LI). Accuracy of VBM was assessed by using NMI, CC, and a simulation analysis.
RESULTS: Overall, DARTEL + LI yielded the most accurate GM maps among the 4 methods (highest NMI and CC, P < .001). DARTEL + LI showed significant GM loss in the bilateral thalami and caudate nuclei in patients with RRMS versus NC. The other 3 methods overestimated the number of regions of GM loss in RRMS versus NC. LI improved the accuracy of both VBM methods. Simulated data suggested the accuracy of the results provided from patient MR imaging analysis.
CONCLUSIONS: We introduce a pipeline that shows promise in limiting segmentation and registration errors in VBM analysis in MS.

Entities:  

Mesh:

Year:  2012        PMID: 22460341      PMCID: PMC3425668          DOI: 10.3174/ajnr.A3083

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  36 in total

1.  Measurement of gray and white matter atrophy in dementia with Lewy bodies using diffeomorphic anatomic registration through exponentiated lie algebra: A comparison with conventional voxel-based morphometry.

Authors:  R Takahashi; K Ishii; N Miyamoto; T Yoshikawa; K Shimada; S Ohkawa; T Kakigi; K Yokoyama
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-15       Impact factor: 3.825

2.  Nonrigid registration of multiple sclerosis brain images using lesion inpainting for morphometry or lesion mapping.

Authors:  Michaël Sdika; Daniel Pelletier
Journal:  Hum Brain Mapp       Date:  2009-04       Impact factor: 5.038

3.  Regional impact of field strength on voxel-based morphometry results.

Authors:  Christine L Tardif; D Louis Collins; G Bruce Pike
Journal:  Hum Brain Mapp       Date:  2010-07       Impact factor: 5.038

4.  Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes.

Authors:  Declan T Chard; Jonathan S Jackson; David H Miller; Claudia A M Wheeler-Kingshott
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

5.  Rhesus macaque brain morphometry: a methodological comparison of voxel-wise approaches.

Authors:  Donald G McLaren; Kristopher J Kosmatka; Erik K Kastman; Barbara B Bendlin; Sterling C Johnson
Journal:  Methods       Date:  2009-10-31       Impact factor: 3.608

6.  Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis.

Authors:  E A Yeh; B Weinstock-Guttman; M Ramanathan; D P Ramasamy; L Willis; J L Cox; R Zivadinov
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

7.  Registration accuracy for VBM studies varies according to region and degenerative disease grouping.

Authors:  J M S Pereira; L Xiong; J Acosta-Cabronero; G Pengas; G B Williams; P J Nestor
Journal:  Neuroimage       Date:  2009-11-03       Impact factor: 6.556

8.  Reducing inter-subject anatomical variation: effect of normalization method on sensitivity of functional magnetic resonance imaging data analysis in auditory cortex and the superior temporal region.

Authors:  Amir M Tahmasebi; Purang Abolmaesumi; Zane Z Zheng; Kevin G Munhall; Ingrid S Johnsrude
Journal:  Neuroimage       Date:  2009-05-27       Impact factor: 6.556

9.  Pitfalls in the use of voxel-based morphometry as a biomarker: examples from huntington disease.

Authors:  S M D Henley; G R Ridgway; R I Scahill; S Klöppel; S J Tabrizi; N C Fox; J Kassubek
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-24       Impact factor: 3.825

10.  Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration.

Authors:  Arno Klein; Jesper Andersson; Babak A Ardekani; John Ashburner; Brian Avants; Ming-Chang Chiang; Gary E Christensen; D Louis Collins; James Gee; Pierre Hellier; Joo Hyun Song; Mark Jenkinson; Claude Lepage; Daniel Rueckert; Paul Thompson; Tom Vercauteren; Roger P Woods; J John Mann; Ramin V Parsey
Journal:  Neuroimage       Date:  2009-01-13       Impact factor: 6.556

View more
  35 in total

1.  Impairments in Walking Ability, Dexterity, and Cognitive Function in Multiple Sclerosis Are Associated with Different Regional Cerebellar Gray Matter Loss.

Authors:  Matthias Grothe; Martin Lotze; Sönke Langner; Alexander Dressel
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

2.  Grey-matter volume as a potential feature for the classification of Alzheimer's disease and mild cognitive impairment: an exploratory study.

Authors:  Yane Guo; Zengqiang Zhang; Bo Zhou; Pan Wang; Hongxiang Yao; Minshao Yuan; Ningyu An; Haitao Dai; Luning Wang; Xi Zhang; Yong Liu
Journal:  Neurosci Bull       Date:  2014-04-23       Impact factor: 5.203

3.  Multi-channel registration of fractional anisotropy and T1-weighted images in the presence of atrophy: application to multiple sclerosis.

Authors:  Eloy Roura; Torben Schneider; Marc Modat; Pankaj Daga; Nils Muhlert; Declan Chard; Sebastien Ourselin; Xavier Lladó; Claudia Gandini Wheeler-Kingshott
Journal:  Funct Neurol       Date:  2015 Oct-Dec

4.  Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study.

Authors:  Koushik A Govindarajan; Sushmita Datta; Khader M Hasan; Sangbum Choi; Mohammad H Rahbar; Stacey S Cofield; Gary R Cutter; Fred D Lublin; Jerry S Wolinsky; Ponnada A Narayana
Journal:  Hum Brain Mapp       Date:  2015-06-19       Impact factor: 5.038

5.  The role of global and regional gray matter volume decrease in multiple sclerosis.

Authors:  Matthias Grothe; Martin Lotze; Sönke Langner; Alexander Dressel
Journal:  J Neurol       Date:  2016-04-19       Impact factor: 4.849

Review 6.  MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment.

Authors:  Massimo Filippi
Journal:  J Neurol       Date:  2014-04-11       Impact factor: 4.849

7.  Brain involvement in patients with inflammatory bowel disease: a voxel-based morphometry and diffusion tensor imaging study.

Authors:  Anastasia K Zikou; Maria Kosmidou; Loukas G Astrakas; Loukia C Tzarouchi; Epameinondas Tsianos; Maria I Argyropoulou
Journal:  Eur Radiol       Date:  2014-07-08       Impact factor: 5.315

8.  Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis.

Authors:  Allan MacKenzie-Graham; Florian Kurth; Yuichiro Itoh; He-Jing Wang; Michael J Montag; Robert Elashoff; Rhonda R Voskuhl
Journal:  JAMA Neurol       Date:  2016-08-01       Impact factor: 18.302

9.  Robust Multiple Sclerosis Lesion Inpainting with Edge Prior.

Authors:  Huahong Zhang; Rohit Bakshi; Francesca Bagnato; Ipek Oguz
Journal:  Mach Learn Med Imaging       Date:  2020-09-29

10.  Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: a voxel-based analysis study.

Authors:  Shahrukh Mallik; Nils Muhlert; Rebecca S Samson; Varun Sethi; Claudia A M Wheeler-Kingshott; David H Miller; Declan T Chard
Journal:  Mult Scler       Date:  2014-08-21       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.